org placeholder image

Zheng Chen

Research Scientist at Mesoblast Limited

  • LinkedIn

Email Email: z****@mesoblast.com

phone noPhone Number: (***)-***-****

map
MESOBLAST LIMITED

MESOBLAST LIMITED

  • description Description
    Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical ne...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Mesoblast Limited Org Chart and Mapping

Employees

Roger Brown

Therapeutic Business Unit Head, Musculoskeletal Repair

John McMannis

Consultant, Cellular Therapies

Jodie Wehling

Vice President of Managed Markets and Sales

Nick Loizos

Vice President, New Technology Development

Susan Sukovich

Senior Director Regulatory Affairs

Christopher James

Vice President, Clinical Operations

Maxine Opperman

Senior Clinical Data Manager/ Data Lead

Frequently Asked Questions Regarding Zheng Chen

Answer: Zheng Chen works for Mesoblast Limited as Research Scientist

Answer: Zheng Chen’s role in Mesoblast Limited is Research Scientist

Answer: Zheng Chen's email address is z***@gmail.com

Answer: Zheng Chen's business email address is z****@mesoblast.com

Answer: Zheng Chen’s direct phone number is (***)-***-****

Answer: Zheng Chen works in the industry of: Biotechnology

Answer: Zheng Chen works Mesoblast Limited located at 505 5th Ave, Melbourne, New York, 10017, United States

Answer: Mesoblast Limited's Research Scientist is Zheng Chen

Answer: Zheng Chen contact details:

  • Phone number  :  (***)-***-****
  • Email  :  z****@mesoblast.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access